Medline Industries, LP has been the subject of 242 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles.
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.
Medline Industries, LP: 0 warning letters, 242 recalls, 0 approval records, 0 Form 483s.
Side by side
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Warning letters0
Medline Industries, LP — Warning letters0
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Recalls1
Medline Industries, LP — Recalls242
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Approval records0
Medline Industries, LP — Approval records0
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Form 483s0
Medline Industries, LP — Form 483s0
Timeline
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
Most recent FDA action: May 13, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles vs Medline Industries, LP: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/central-admixture-pharmacy-services-inc-caps-los-angeles-vs-medline-industries-lp
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗